stella
beta
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations — Stella
Recruiting
Back to Early T Acute Lymphoblastic Leukemia trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Ethical Committee of the First Affliated Hospital of Soochow University, Suzhou, Jiangsu
View full record on ClinicalTrials.gov